Dissertations / Theses on the topic 'NFE2'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 49 dissertations / theses for your research on the topic 'NFE2.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
AMARU, CALZADA ARIEL. "Mechanism of action of Histone Deacetylase inhibitor. Givinostat in Chronic Myeloproliferative neplasm." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2013. http://hdl.handle.net/10281/44363.
Full textEllingsen, Rikke. "Nonlinear Isogeometric Analysis vs NFEA of Tubular Joints." Thesis, Norges teknisk-naturvitenskapelige universitet, Institutt for konstruksjonsteknikk, 2013. http://urn.kb.se/resolve?urn=urn:nbn:no:ntnu:diva-21878.
Full textDahmani, Younes. "Uttryck av Nfr2 och dess kliniska roll i klarcellig njurcancer." Thesis, Umeå universitet, Biomedicinsk laboratorievetenskap, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-58605.
Full textChesney, James R., Nicholas J. Speciale, and Anil K. Agrawal. "Design of the TOPEX-NFEP Utilizing the Functional Component Approach." International Foundation for Telemetering, 1989. http://hdl.handle.net/10150/614728.
Full textTOPEX/POSEIDON is a joint American/French Ocean Topography Experiment undertaken by the National Aeronautics and Space Administration (NASA) and Center National d'Etudes Spatiales (CNES) to acquire, process and verify altimetric sea surface height data so that mean and variable geotropic surface currents of the world's oceans can be mapped. This paper describes the functions and the architecture of the proposed front end to the Telemetry, Command and Communication System (TCCS) used for monitoring the spacecraft health, real time analysis required for supporting satellite analysis, collecting the telemetry data, and commanding the satellite. The system uses specialized hardware developed (herewith called as NFEP) at Goddard Space Flight Center to offload the Host processing and to support the data acquisition in a stand alone mode even in case of failure of the Host machine. The NFEP utilizes the semi-custom and custom very large scale integration (VLSI) devices, microprocessor control, and programmable logic designed to provide a generic NASA Communication (NASCOM) block processing and telemetry frame synchronization.
Bruder, Carl E. G. "Genetic analysis of neurofibromatosis type 2 (NF2) patients and NF2-associated tumors with emphasis on chromosome 22 deletions /." Stockholm, 2000. http://diss.kib.ki.se/2000/91-628-4370-2/.
Full textVahldiek, Kai-Felix. "Allelverluste bei Neurofibromatose Typ 2 (NF2) assoziierten Meningeomen." [S.l.] : [s.n.], 2001. http://deposit.ddb.de/cgi-bin/dokserv?idn=965649512.
Full textKlungsupya, P. "Nucleotide excision repair of the plasmid borne NFA2 gene in Saccharomyces cerevisiae." Thesis, Swansea University, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.637808.
Full textVigorito, Christian. "Implementazione di algoritmi di stima della distanza con segnali a bassa frequenza." Bachelor's thesis, Alma Mater Studiorum - Università di Bologna, 2012. http://amslaurea.unibo.it/3534/.
Full textSchmid, M. C. "The role of focal adhesion kinase (FAK) in NF2 -/- turmourigenesis." Thesis, Exeter and Plymouth Peninsula Medical School, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.701076.
Full textJohnson, Kristen C. (Kristen Carrie) 1976. "Analysis of the function of the Nf2 tumor suppressor protein, Merlin." Thesis, Massachusetts Institute of Technology, 2003. http://hdl.handle.net/1721.1/29763.
Full textVita.
Includes bibliographical references.
The Neurofibromatosis type 2 tumor suppressor gene (NF2) is mutated in inherited and sporadically occurring central nervous system tumors. The NF2 encoded protein, merlin, shares close sequence similarity in its amino-terminal domain to members of the band 4.1 family of membrane-cytoskeletal linkers. Similarities between merlin and this family suggest a role for merlin in regulating cytoskeletal function. Thus, NF2 may be a novel type of tumor suppressor gene that mediates its tumor suppressor function through interactions with the actin cytoskeleton. However, the molecular and cellular functions of this tumor suppressor gene were largely unknown when the work described here began. Mutational analysis of Nf2 in flies has lead to the identification of a dominant-negative allele, which harbors mutations in the amino-terminal domain of the protein. The work presented here demonstrates that expression of a murine analog of this amino-terminal mutant of Nf2 (termed, Nf2BBA) leads to complete transformation of NIH3T3 fibroblasts in culture. Cells that express Nf2BBA display disruptions of the actin cytoskeleton, lack of contact inhibition of growth, and anchorage-independent growth. In addition, Nf2-deficient mouse embryo fibroblasts (MEFs) exhibited similar contact inhibition and cell-matrix adhesion defects to Nf2BBA expressing cells. Nf2BBA cells continue to cycle under normal growth inhibitory conditions, such as serum withdrawal, and exhibit high levels of the cell cycle regulator, cyclin D1. Elevated levels of cyclin D1 are necessary for cellular transformation following Nf2BBA expression. Nevertheless, the exact mechanism by which Nf2BBA results in cellular transformation remains elusive. Recently published studies have revealed that merlin may regulate members of the RhoGTPase
(cont.) family, as absence of Nf2 expression in fibroblasts leads to many phenotypes reminiscent of overactive Rac, such as increased membrane ruffling and increased activity of the c-jun N- terminal kinase (JNK). Our work has extended to the analysis of the role of merlin in the regulation of the Rac pathway. Using rat schwannoma cells and N2-deficient MEFs, we have demonstrated that merlin exerts its inhibitory effects downstream of Rac, through a direct interaction with the p21 activated kinase, Pak. We demonstrate that in the absence of merlin, Pak is active and hyperphosphorylated, and, conversely, when merlin is overexpressed, Pak activity is diminished. The N-terminal half of merlin binds to the functionally conserved Rac/Cdc42 interaction binding (CRIB) domain of Pak. Several models for merlin regulation of Pak activity will be discussed. Finally, the identification of Pak as a kinase that is misregulated in the absence of NF2 may lead to possible avenues for therapeutic intervention.
by Kristen C. Johnson.
Ph.D.
Schulze, Karin Marlies Marion. "Herstellung rekombinanter Retroviren, In-vitro-Gentransfer und Expressionsanalyse des NF2-Gens Merlin." [S.l. : s.n.], 2001. http://deposit.ddb.de/cgi-bin/dokserv?idn=962345210.
Full textMason, Susan. "Investigating pathological mutations in the neurofibromatosis type 2 tumour suppressor gene." Thesis, University of Newcastle Upon Tyne, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.245083.
Full textFlynn, Sara Jane. "A comparative and exploratory study of the Nfer-Nelson Emotional Literacy Scale in an Irish context." Thesis, University of Exeter, 2010. http://hdl.handle.net/10036/3041.
Full textChen, Yaxiong. "Characterization of chicken NF2/merlin and its functions in early limb muscle development /." free to MU campus, to others for purchase, 2003. http://wwwlib.umi.com/cr/mo/fullcit?p3115532.
Full textZhan, Yu. "Mixed Lineage Kinase 3 Signaling in Ovarian Cancer and Neurofibromatosis-2." University of Toledo / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1310127039.
Full textThaxton, Courtney Lynn. "Mechanisms Promoting Phosphorylation of the NF2 Tumor Suppressor and its Effects on Schwann Cell Development." Doctoral diss., University of Central Florida, 2007. http://digital.library.ucf.edu/cdm/ref/collection/ETD/id/2154.
Full textPh.D.
Department of Biomolecular Science
Burnett College of Biomedical Sciences
Biomolecular Sciences PhD
Manent, Jan. "Analyse fonctionnelle du gène suppresseur de tumeur NF2 impliqué dans la Neurofibromatose de type 2." Paris 6, 2006. http://www.theses.fr/2006PA066296.
Full textDEGUEN, BRIGITTE. "Modeles cellulaires permettant l'etude fonctionnelle de la schwannomine, produit du gene suppresseur de tumeurs nf2." Paris 11, 1998. http://www.theses.fr/1998PA112158.
Full textMani, Timmy. "The Role of Phosphoinositide Binding in Merlin Function." University of Cincinnati / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1299181100.
Full textBeltrami, Sarah. "NEUROFIBROMATOSIS TYPE 2 PROTEIN (NF2) AS A REGULATOR OF TUMOR SUPPRESSORS AND VIRAL ONCOPROTEINS IN HUMAN GLIOBLASTOMA." Diss., Temple University Libraries, 2014. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/239188.
Full textPh.D.
Glioblastomas are the most common brain malignancy occurring in adults with the worst prognosis. Several obstacles have prevented the development of efficacious treatment strategies. Due to the insidious nature of these malignancies, tumors are not typically detected until late in the disease. Further, the delicate nature of surrounding normal brain tissue makes surgery and treatment with cytotoxic chemotherapeutics detrimental to the patient's quality of life. Despite decades of research and aggressive therapeutic strategies, most patients will develop recurrent tumors and succumb to the disease within 1 year of diagnosis. An enhanced understanding of the molecular interplay among tumor suppressors and oncoproteins can greatly contribute to the development of novel therapeutics that will extend life expectancies. The most common abnormality in these tumors is mutation of the p53 gene (TP53). Due to the expansive network of p53-responsive genes, loss of functional p53 prohibits the cell to the ability to regain control of aberrant proliferation in response to oncogenic stresses. Accordingly, glioblastomas have developed several mechanisms to inactivate this potent tumor suppressor. Similar to oncoproteins, viral regulatory proteins utilize p53 to prevent cell cycle arrest. One such example is the protein associated with the human polyoma virus, JC Virus (JCV). JCV is the etiologic agent of the fatal demyelinating disorder, Progressive Multifocal Leukoencephalopathy (PML), seen in severely immunocompromised patients. Infection of oligodendrocytes with JCV leads to their lytic destruction and the development of white matter lesions in PML patients. Its main regulatory protein, large tumor antigen (T-antigen), targets p53 to retain cells in a virus-producing state, thereby conveying an accidental oncogenicity. JCV T-antigen transgenic mice develop a multitude of CNS tumors, including malignant peripheral nerve sheath tumors similar to patients with a form of Neurofibromatosis. Neurofibromatosis types 1 and 2 are inherited cancer disorders resulting from the inactivation of their specific tumor suppressor genes, NF1 and NF2, respectively. Inactivation of the NF2 gene, results in the development of several multiple benign nervous system tumors. Traditionally, NF2 is viewed as a scaffolding protein primarily located at the plasma membrane, where it prevents excessive signaling via several cell surface receptors and their cytoplasmic kinases. NF2 links receptors at the plasma membrane to their cytoplasmic kinases to facilitate contact inhibition. However, NF2 can also interact with an array of cytoplasmic and a few nuclear proteins. To date, little is known about the function of NF2 in tumors not associated with NF2 syndrome. Loss of functional NF2 protein has become a staple of several sporadic cancers including mesotheliomas, and meningiomas. In glial cells, NF2 depletion results in hyperproliferation and development of oncogenic features. In the only prior report addressing the role of NF2 inactivation in glioblastoma, another group demonstrated that NF2 is a potent inhibitor of glioblastoma growth. Previously, our group has identified JCV T-antigen as a nuclear binding partner for NF2 in tumors derived from JCV T-antigen transgenic mice. The association of NF2 with T-antigen in neuronal origin tumors led us to hypothesize that NF2 could regulate the expression of the JCV T-antigen. Here, we report that NF2 suppresses T-antigen protein expression in U-87 MG human glioblastoma cells, which subsequently reduces T-antigen-mediated regulation of the JCV promoter. When T-antigen mRNA was quantified, it was determined that increasing expression of NF2 correlated with an accumulation of T-antigen mRNA; however, a decrease in T-antigen at the protein level was observed. NF2 was found to promote degradation of ubiquitin-bound T-antigen protein via a proteasome dependent pathway concomitant with the accumulation of the JCV early mRNA encoding T-antigen. The interaction between T-antigen and NF2 maps to the FERM domain of NF2 domain of NF2, which has been shown previously to be responsible for its tumor suppressor activity. Co-immunoprecipitation assays performed on a glioblastoma cell line revealed a ternary complex consisting of NF2, T-antigen, and the tumor suppressor protein, p53. Furthermore, these proteins were detected in various degrees in tumor specimens from patients, suggesting that these associations may occur in vivo. Collectively, these results demonstrate that NF2 negatively regulates JCV T-antigen expression by proteasome-mediated degradation, and suggest a novel role for NF2 as a suppressor of JCV T-antigen-induced oncogenesis. Studies in mouse and human tumors have inferred a relationship between NF2 and the primary target for JCV T-antigen, p53. In mouse models of cancer, concurrent loss of NF2 and p53 genes generates a highly malignant phenotype. Other groups reported that loss of NF2 and p53 in human tumors correlated with enhanced tumor grade. In transformed fibroblasts, NF2 can enhance the expression of p53 and promote p53-mediated apoptosis. However, the molecular details of the NF2 and p53 relationship have not yet been elucidated. Based on our data and previous literature, we believed that there is a tumor suppressive synergy that exists between NF2 and p53. Contrary to our expectations, we discovered that NF2 overexpression in U-87 MG cells results in the decline in p53 expression. We observed this effect in the p53-null cell line, Saos2, and in the presence of proteasome inhibitors. Further, we determined that NF2 utilizes cysteine proteases as part of a post translational mechanism to suppress p53 expression. Mutant p53, present in many glioblastomas, was resistant to NF2-mediated degradation. Additionally, we determined that p53 can reciprocally repress NF2 expression, by a post translational mechanism, independent of the proteasome, lysosome, or cysteine proteases. NF2 conformation mutants, S518A and S518D, can both degrade p53 and localize to the cytoplasm. However, the constitutively inactive, open form of NF2, S518D is resistant to p53-mediated degradation. NF2 and p53 do not directly interact, yet we were able to detect these proteins in the same patient glioblastoma samples. Using a conformation-specific antibody, we speculate that the majority of our glioblastoma samples may contain mutated p53. This novel relationship between NF2 and p53 we believe will have strong implications for chemotherapeutic sensitization of these typically resistant tumors. Cumulatively, these studies will provide evidence for novel tumor suppressive roles for NF2 and a greater understanding of the molecular events that shape glioblastoma progression.
Temple University--Theses
Kukuyan, Anna-Mariya. "ROLE OF BAP1 IN MESOTHELIOMA AND MELANOMA PREDISPOSITION." Diss., Temple University Libraries, 2019. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/556760.
Full textPh.D.
BAP1 (BRCA-Associated Protein1) is a tumor suppressor gene encoding a deubiquitinating enzyme (DUB) that regulates many facets of cellular biology. Genetic studies have demonstrated that somatic BAP1 mutations occur in numerous cancer types and that germline BAP1 mutations lead to a cancer susceptibility disorder that predisposes individuals to various tumors, in particular malignant mesothelioma (MM) and both uveal melanoma (UM) and cutaneous melanoma (CM). The Testa laboratory has identified several families (including one in Louisiana, designated Lou) with germline BAP1 mutations, in which there were recurrent cases of MM, UM, and CM. We generated a Bap1 mutant mouse model with a knockin mutation identical to that observed in the Lou family (Bap1+/Lou ) to test whether this mutation alone confers susceptibility to ultraviolet (UV) light-induced melanomagenesis either alone or in combination with a mutation found in a well-established Hepatocyte Growth Factor (HGF)/Scatter Factor transgenic mouse model. Neither Bap1+/Lou, HGF, nor Bap1+/Lou;HGF mice showed a significantly higher incidence or shorter latency of UV light-induced melanoma than wild type (WT) mice. The study also suggests that germline mutation of Bap1 alone does not cause an increased incidence of UV-induced melanomas under the conditions used in this investigation. Recent evidence indicates that BAP1 participates in the DNA damage repair response, suggesting that BAP1’s role in tumorigenesis could be particularly important in cancers associated with environmental carcinogens such as ultraviolet irradiation (UVR). To further investigate the role of BAP1 (Bap1 in the mouse) in DNA damage, we first knocked down BAP1 in human melanocytes as well as Melan-A and Melan-C mouse melanocytes and then exposed the cells to UVR, followed by analysis of DNA damage repair. UVR-induced and steady state levels of DNA damage were higher in BAP1-knockdown cells compared to shGFP-control cells. Levels of UVR-related DNA damage markers such as p53, γH2AX and CPD (cyclobutane pyrimidine dimers) were increased following BAP1 loss and UVR treatment. Cell cycle analysis by flow cytometry demonstrated that cells with knockdown of BAP1 and post UVR treatment showed a higher proportion of cells in S/G2 phase. Such an effect could be due to BAP1 loss and consequent inability to repair DNA damage and/or cell cycle progression. These data are consistent with a role for BAP1 in UVR-induced DNA damage repair. In MM, it is unclear to what extent BAP1 mutations cooperate tumorigenically with mutations of other tumor suppressor genes (TSGs) implicated in MM, such as CDKN2A and NF2. While germline mutations of BAP1 clearly predispose to MM, whether somatic mutations of BAP1 drive a more aggressive, metastatic tumor phenotype may depend on the disease type. For such studies, we used conditional knockout (CKO) mice along with intrathoracic (IT) or intraperitoneal (IP) injection of adenovirus expressing Cre recombinase (Adeno-Cre) to excise critical homozygously floxed TSGs in the mesothelial lining. These labor-intensive experiments demonstrated that while homozygous deletion of Bap1, Cdkn2a, or Nf2 alone in the pleural cavity (IT) of genetically engineered mouse (GEM) models gave rise to few or no MMs, inactivation of Bap1 cooperated with loss of either Nf2 or Cdkn2a to drive development of MM in ~20% of double CKO mice, and a high incidence (22/26, 85%) of MMs with short latency (12 weeks) was observed in Bap1;Nf2;Cdkn2a (triple)-CKO mice. The same trend was confirmed when the same gene combinations were homozygously deleted IP in these same GEM models, except that a much higher incidence of MM was observed in homozygously floxed Bap1 (Bap1f/f) mice injected IP versus IT, which may be due to a larger cell surface area of the peritoneum. Adeno-Cre treatment of normal mesothelial cells from Bap1f/f;Nf2 f/f;Cdkn2 f/f mice, but not from mice with knockout of one or any two of these tumor suppressor genes, resulted in robust spheroid formation in vitro, suggesting that homozygous deletion of all three of these TSGs is sufficient to drive a cancer stem cell-like potential. RNA-seq analysis of pleural MMs from triple-CKO mice revealed enrichment of many genes transcriptionally regulated by the polycomb repressive complex 2 (PRC2). Other genes upregulated in MMs from triple-CKO mice included Vegfd and Pak3, which encode proteins involved in angiogenic and cell motility pathways. In conclusion, we hypothesize that inherited mutations of BAP1 may increase susceptibility to certain environmental factors that may induce DNA damage and contribute to cancer development. Our data also indicate that cooperative somatic inactivation of Bap1, Nf2, and Cdkn2a results in rapid, highly aggressive MMs, and that deletion of Bap1 contributes to tumorigenesis, in part, by loss of PRC2-mediated gene repression of tumorigenic target genes and by acquisition of stem-cell potential. Thus, our studies suggest a potential avenue for therapeutic intervention.
Temple University--Theses
Worseck, Josephine Maria. "Characterization of phosphorylation-dependent interactions involving neurofibromin 2 (NF2, merlin) isoforms and the Parkinson protein 7 (PARK7, DJ1)." Doctoral thesis, Humboldt-Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, 2012. http://dx.doi.org/10.18452/16533.
Full textAlterations in phosphorylation-dependent signalling pathways, accumulation of aggregated proteins in the brain and neuronal apoptosis are common to neurodegeneration and implicate overlapping molecular mechanism. To gain insight into involved pathways, a modified yeast-two hybrid (Y2H) system was applied to screen 71 proteins associated with neurological disorders in a proteome-wide manner. For 21 of these proteins interactions were identified including 5 phosphorylation-dependent ones. In total, the network connected 79 proteins through 90 protein-protein interactions (PPIs). A fraction of these Y2H PPIs was tested in secondary interaction assays with a validation rate of 66 %. The described network-based approach successfully identified proteins associated with more than one disorder and cellular functions connected to specific disorders. In particular, the network revealed Ser/Thr kinase-dependent PPIs between the Parkinson protein 7 (PARK7, DJ1) and the E3 ligase components ASB3 and RNF31 (HOIP). The function of these proteins further substantiates the established connection between Parkinson’s disease (PD) and ubiquitination-mediated proteasome (dis)functions. Neurofibromin 2 (NF2, merlin) isoforms and PARK7 were identified as PI3K regulatory subunit p55-gamma (PIK3R3) interactors. These PPIs required Tyr kinase coexpression in the modified Y2H system and functional PIK3R3 pTyr-recognition modules (SH2 domains) in co-IP and Venus PCA experiments. This finding implicates the PI3K/AKT survival pathway in PD-associated neuronal apoptosis and Neurofibromatosis type 2-associated tumour formation. Investigation of PIK3R3, AOF2 (KDM1A, LSD1) and EMILIN1 PPIs on NF2 isoform level revealed preferential isoform 7 binding and cytoplasmic or membrane localisation of these PPIs for isoform 7 or 1, respectively. The generated modification-dependent and isoform-specific PPI network triggered many hypotheses on the molecular mechanisms implicated in neurological disorders.
Hamza, Kankia Ibrahim. "Design and development of novel tools for the screening and identification of inhibitors of HER receptor family and NFR2 for ovarian cancer therapy." Thesis, Abertay University, 2017. https://rke.abertay.ac.uk/en/studentTheses/441e2039-1bde-448b-9c87-d2845ac1da96.
Full textSperka, Tobias [Verfasser]. "Ein neuer, regulierter Komplex des NF2-Tumorsuppressor-Genproduktes Merlin mit p190RhoGAP und p120RasGAP / Forschungszentrum Karlsruhe GmbH, Karlsruhe. Tobias Sperka." Karlsruhe : FZKA, 2006. http://d-nb.info/978199979/34.
Full textPeyre, Matthieu. "Modélisation de la tumorigenèse méningée chez la souris : progression tumorale liée à Nf2 et Cdkn2ab et voies alternatives d'oncogenèse." Paris 7, 2013. http://www.theses.fr/2013PA077109.
Full textMeningioma is the most common primary nervous System tumor. Although most tumors are benign , they can recur even after total resection, present with significant morbidity and there is a growing proportion, up to 30%, of aggressive variants (WHO grade II and III). The creation of relevant genetically engineered mouse models is the cornerstone of future advances in meningioma treatment through pre-clinical testing and thorough dissection of molecular mechanisms of tumorigenesis. We here present the creation and characterization in vivo and in vitro of two new genetically engineered mouse models of meningioma : one model of Grade ll-lll meningioma through bi-allelic A//2 inactivation and homozygous Cdkn2ab deletion and one model of PDGF-(3-induced meningioma, with or without bi-allelic A//2 inactivation. On the basis of recent whole genome studies, we also set the bases of two future A//2-independant GEM meningioma models through Akt and Smo activation. The establishment of mouse meningioma cell lines and a syngenic orthotopic meningioma mouse model allowed the evaluation of a new handheld confocal imaging device and will eventually lead to future « co-trials »
Boin, Alizée. "Le rôle de la voie Hippo dans la fonction suppresseur de tumeur associée au gène NF2 et la régulation de Yap par Merlin dans les cellules de Schwann." Thesis, Paris 11, 2014. http://www.theses.fr/2014PA112282.
Full textSchwannomas are benign tumors arising from Schwann cell hyper-proliferation under NF2 bi-allelic inactivation. They appear in the context of a rare hereditary disease called Neurofibromatosis type 2 (NF2) or in sporadic cases. To this day, surgery and radiotherapy remain the only options to treat these patients, mainly due to the lack of therapeutical targets identified. The NF2 loss associated cellular phenotype is the loss of cell contact inhibition. Two main functions of Merlin, the NF2 product, have emerged in the last decade. The first was shown by our group and consists in the accumulation of tyrosine kinase receptors (RTK) at the plasma membrane in schwannomas. The second involves Merlin in the regulation of the Hippo signaling pathway. This pathway is activated by cell contact and inactivates a couple of transcription co-factors, Yap and Taz, then participating in cell contact inhibition of proliferation. However, the mechanisms by which Merlin inactivates Yap and Taz remain unknown. In our studies, we aimed to determine both the molecular signature of human schwannomas taking advantage of a large proteomic study, and the relative importance of Yap in the tumor suppressor function of Merlin. We could show both a specific activation of five RTKs : PDGFRβ, Her 3, Her2, Axl and Tie2 and a specific nuclear accumulation of Yap in human schwannoma. Among all the protein studied, Yap, PDGFRβ and P-Her3 are the only ones to correlate with the proliferation of human schwannoma cells. Furthermore, the activated RTK (excepted Tie2) are transcriptional targets of Yap. Hence, we found Yap as a pivotal regulator of schwannoma growth and proposed its inhibition as a new and promising therapeutical target to reduce human schwannoma growth. In addition, we show that Merlin specifically inhibits Yap nuclear translocation into the nucleus of Schwann cells by a direct interaction which is independent from the regulation by cell density and by the Hippo pathway. Moreover, Merlin expression seems not to be essential for Hippo activation in Schwann cells which brings a new and unexpected role of Merlin in Yap and Hippo regulation. In the end, we studied the role of AmotL1, a strong Hippo partner of Merlin in the migration and progression of breast cancer. We could show an antagonist function of Merlin and AmotL1 in the promotion of these mechanisms highlighting a new progression suppressor function of Merlin in cancer which are not linked to NF2 mutations
Provenzano, Lucy. "The role of cellular prion protein in the development of schwannomas and other Merlin-deficient tumours." Thesis, University of Plymouth, 2018. http://hdl.handle.net/10026.1/10784.
Full textAndersson, Malin, and Daniel Svensson. "Impacts on teachers' lives of a capacity building course: A case study in rural Rajasthan, India." Thesis, Linnéuniversitetet, Institutionen för pedagogik, psykologi och idrottsvetenskap, PPI, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-12807.
Full textSchulz, Alexander [Verfasser], Reinhard [Akademischer Betreuer] Wetzker, Reinhard [Akademischer Betreuer] Bauer, and Stephan [Akademischer Betreuer] Baader. "Die Rolle des Tumorsuppressorproteins Merlin bei der Pathogenese von NF2-assoziierter Polyneuropathie / Alexander Schulz. Gutachter: Reinhard Wetzker ; Reinhard Bauer ; Stephan Baader." Jena : Thüringer Universitäts- und Landesbibliothek Jena, 2015. http://d-nb.info/1066238359/34.
Full textMcLain, John. "The Deletion of Exon 2 in the Nf2 Gene Leads to Changes in Morphology, Protein Expression, and Localization in Mouse Schwann Cells." Honors in the Major Thesis, University of Central Florida, 2007. http://digital.library.ucf.edu/cdm/ref/collection/ETH/id/1179.
Full textBachelors
Burnett School of Biomedical Sciences
Molecular Biology & Microbiology
Islam, Mohammed Mehrul. "An analysis of the role of extension methodology on poverty reduction : a comparative study of aquaculture extension programmes in the Northwest Fisheries Extension Project (NFEP) command area, Bangladesh." Thesis, University of Wolverhampton, 2002. http://hdl.handle.net/2436/29559.
Full textLyons, Rimmer Jade. "The potential of CRL4-DCAF1 and KSR1 as therapeutic targets in low-grade Merlin-deficient tumours." Thesis, University of Plymouth, 2018. http://hdl.handle.net/10026.1/12833.
Full textMönch, Dina [Verfasser], and German [Akademischer Betreuer] Ott. "Identifizierung von Zielmolekülen für die innovative Therapie pleuraler Mesotheliome : Untersuchung von Tyrosinkinasen sowie Komponenten der NF2/mTOR- und p14/p16-Signalwege / Dina Mönch ; Betreuer: German Ott." Hohenheim : Kommunikations-, Informations- und Medienzentrum der Universität Hohenheim, 2020. http://d-nb.info/1220774723/34.
Full textAndujar, Pascal. "Altérations génétiques des tumeurs respiratoires humaines et murines après exposition à des fibres minérales." Thesis, Paris Est, 2008. http://www.theses.fr/2008PEST0030.
Full textRésumé en anglais non communiqué
Frykholm, Carina. "Clinical and Genetic Studies of Hearing Impairment." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Universitetsbiblioteket [distributör], 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8290.
Full textMoncrieffe, Melissa Lucille. "Analyzing a model of non-formal education for young people : a comparative case study of national programs in the United States and Scotland." Thesis, University of Edinburgh, 2016. http://hdl.handle.net/1842/23568.
Full textWorseck, Josephine [Verfasser], Christian [Akademischer Betreuer] Spahn, Erich E. [Akademischer Betreuer] Wanker, and Hans [Akademischer Betreuer] Lehrach. "Characterization of phosphorylation-dependent interactions involving neurofibromin 2 (NF2, merlin) isoforms and the Parkinson protein 7 (PARK7, DJ1) / Josephine Maria Worseck. Gutachter: Christian Spahn ; Erich E. Wanker ; Hans Lehrach." Berlin : Humboldt Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, 2012. http://d-nb.info/1023931621/34.
Full textIvins, Tiffany. "Localization of Open Educational Resources (OER) in Nepal: Strategies of Himalayan Knowledge-Workers." BYU ScholarsArchive, 2011. https://scholarsarchive.byu.edu/etd/2616.
Full text横山, 俊彦, 啓隆 長田, 秀樹 村上, 義朗 立松, 哲郎 谷口, 豊. 近藤, 豊明 樋田, 好規 長谷川, 薫. 下方, and 好孝 関戸. "O-28 YAP1は悪性胸膜中皮腫の増殖を促進し,NF2腫瘍抑制遺伝子で機能阻害される." 日本肺癌学会, 2007. http://hdl.handle.net/2237/11031.
Full textBuckley, Patrick. "Development and Application of Microarray-Based Comparative Genomic Hybridization : Analysis of Neurofibromatosis Type-2, Schwannomatosis and Related Tumors." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4786.
Full textWu, Yi-Ci, and 巫逸琦. "NFE2-related factor 2 (Nrf2) in neurodegenerative disease: promoter polymorphism and therapeutic strategy targeting oxidative stress." Thesis, 2012. http://ndltd.ncl.edu.tw/handle/52764583766979550531.
Full text國立臺灣師範大學
生命科學研究所
100
Nuclear factor-erythroid 2 (NF-E2)-related factor 2 (Nrf2) is a member of the basic leucine zipper transcription factors that regulate the expression of many antioxidant pathway genes and maintains cellular redox homeostasis. Increased oxidative stress is involved in the pathogenesis of many neurodegenerative diseases. For example, oxidative stress has been implicated as a major contributing factor in Parkinson’s disease (PD) and varying efficiency in the oxidative protection by Nrf2 may influence PD pathogenesis. In polyQ-mediated spinocerebellar ataxias, the expansions of translated CAG repeats in the disease genes result in long polyQ tracts in the respective proteins, leading to accumulation of aggregated polyQ proteins and increased oxidative stress. In this study, PCR-RFLP test was developed to examine the frequency of Nrf2 -653 A/G, -651 G/A and -617 C/A promoter polymorphisms in a larger cohort of PD (n = 480, 49.2% female, age at onset 61.8±11.2 years) and age- and gender-matched controls (n = 526, 50.5% female, age 60.3±13.1 years). No association between polymorphic genotype, allele or haplotype and PD was observed. In addition, Flp-In SH-SY5Y cells with ATXN3/Q14~75 expression in an inducible fashion were established. In retinoic acid-induced differentiated SH-SY5Y cells, the expressed ATXN3/Q75 formed aggregates, accompanying with reducing neurite outgrowth. By combining high content image analysis and immunoblotting, treatment of ATXN3/Q75 cells with Chinese herbs NH004, NH008, NH021 and NH008 derivative NH008-1 activate Nrf2 expression, accompanying decreasing ATXN3/Q75 aggregates. Thus NH004, NH008, NH021 and NH008-1 may be potential therapeutic strategies for polyQ-mediated disease.
Huang, Zih-Ming, and 黃梓銘. "Utilized NFES piezoelectric fibers to fabricate all-directional or transparent graphene-based generators." Thesis, 2015. http://ndltd.ncl.edu.tw/handle/61732667263805846646.
Full text國立中央大學
機械工程學系
103
In this thesis, the near-field electrospinning (NFES) technique was used to investigate the piezoelectric fibers and fabricated the nanogenerators. The major research focused on (1) Massively aligned nanofibers-based nanogenerator deposited via near-field electrospinning, (2) An arbitrarily directional piezoelectric fiber-based nanogenerator with concentric circle topography via near-field electrospinning, (3) A transparent and flexible graphene-piezoelectric fiber generator. We demonstrate a direct-write, in-situ poled polyvinylidene fluoride (PVDF) nanofiber arrays that could functions as a self-powered active deformation sensor or harvester. This research is different from previous electrospinning research, however the fibers were mostly patterned in parallel lines and they could be actuated in limited direction only. We fabricated this apparatus precisely via near field electrospinning which has a spectacular concentric circle topography which made it possible to collect the mechanical energy from various directions. Furthermore, we also utilized the graphene as electrode to fabricate a flexible and transparent NG. Compared to previous opaque Cu-foil electrode, the graphene based NG has a promising future in the applications of smart phone or wearable electronics as a self-power system.
Fan, Kai-Chun, and 范凱鈞. "Linkage Identification by NFE Estimation: A Practical View of Building Blocks." Thesis, 2011. http://ndltd.ncl.edu.tw/handle/75775699893946234753.
Full text國立臺灣大學
電機工程學研究所
99
Competent genetic algorithms (competent GAs) identify linkages between genes and build models via various mechanisms to solve problems. They have been applied for real world applications, but whether the models given by them match what are really preferred to solve the problems is yet unknown. This thesis proposes using the number of function evaluation (Nfe) to measure the performance of models and defines the optimal model to be the one that consumes the fewest Nfe for GAs to solve a specific problem. Then the building blocks (BBs) that construct the optimal model are defined as the correct BBs, and correct linkages exist between any two genes which locate in the same BB. The capabilities of existing linkage-identification metrics, including non-linearity, entropy, simultaneity and DMC, are compared based on this definition. We find that all these metrics fail to identify correct linkages for some typical problems intrinsically. This thesis then proposes a new metric, named eNFE, directly based on the idea of Nfe to enhance the existing linkage-identification metrics. Experiment results show that eNFE is able to identify correct linkages for examined problems. The preliminary success suggests another view on learning linkage.
Wiederhold, Thorsten [Verfasser]. "Characterization of neurofibromatosis 2 (NF2) tumor suppreor binding proteins / vorgelegt von Thorsten Wiederhold." 2001. http://d-nb.info/966515188/34.
Full textVahldiek, Kai-Felix [Verfasser]. "Allelverluste bei Neurofibromatose Typ 2 (NF2) assoziierten Meningeomen / vorgelegt von Kai-Felix Vahldiek." 2001. http://d-nb.info/965649512/34.
Full text鄧旭真. "Molecular Characterization of Germline Mutations in Brain Tumor NF2 Gene and Breast Cancer BRCA2 Gene from Taiwan." Thesis, 1997. http://ndltd.ncl.edu.tw/handle/31752464570994698246.
Full text國立中山大學
生命科學研究所
85
Neurofibromatosis type 2 (NF2) is an autosomal dominantly inherited disease by bilateral vestibular schwannomas and other tumor of the brain, spinal cord, and central nervous system. NF2 disease is caused by germline mutations in the NF2 tumor suppressor gene on chromosome 22q12. Although the tumors of NF2 are histologically benign, their anatomical location and multiplicity lead to great morbidity and early mortality. Breast cancer is the most common malignancy among women in developed countries. Recently, the incidence of breast cancer increases n Taiwan and the occurrence of breast cancer tends to be early onset. Familial breast cancer is characterized by early onset, an increased risk of bilateral breast cancer, an increasing risk and numbers of affected family members. The second breast cancer susceptibility gene, BRCA2 on chromosome 13q12-13, has recently been cloned. Germline mutations of BRCA2 are predicted to account for approximately 35% of families with early onset female breast cancer, and they are also associated with an increased risk of male breast cancer. To identify the nature of genetic mutations in familial brain tumor and breast cancer in Taiwan and develop simple diagnosis procedures for detecting these genetic mutations, we have analyzed germline mutations in the NF2 gene and BRCA2 gene by PCR (polymerase chain reaction) -based SSCP (single strand conformation polymorphism) analysis followed by cloning and sequencing of related PCR products. In this study, nonsense mutations or frameshift deletions in NF2 and BRCA2 genes had been found, and these mutations are all predicted to lead to the truncated proteins which are usually associated with severe phenotypes. Moreover, polymorphic changes of several missense and silent mutations were also observed among breast cancer patients and normal individuals. The search for genotype-phenotype correlation in NF2 and BRCA2 mutations is important not only to increase understanding of how mutated genes function, but also to improve presymptomatic detection of patients. DNA diagnosis of NF2 gene and BRCA2 gene can improve quality of genetic counseling and clinical management, and possibly reduce psychosocial difficulties in at-risk individuals.
Schulze, Karin Marlies Marion [Verfasser]. "Herstellung rekombinanter Retroviren, In-vitro-Gentransfer und Expressionsanalyse des NF2-Gens Merlin / vorgelegt von Karin Marlies Marion Schulze." 2001. http://d-nb.info/962345210/34.
Full textGehlhausen, Jeff R. "Phenotypic and molecular characterization of a novel mouse model of neurofibromatosis type 2." Thesis, 2015. http://hdl.handle.net/1805/7947.
Full textNguyen, Hoa Bich. "The tumor suppressing roles of tissue structure in cervical cancer development." Thesis, 2013. http://hdl.handle.net/1805/3627.
Full textCervical cancer is caused by the persistent infection of human papilloma virus (HPV) in the cervix epithelium. Although effective preventative care is available, the widespread nature of infection and the variety of HPV strains unprotected by HPV vaccines necessitate a better understanding of the disease for development of new therapies. A major tumor suppressing mechanism is the inhibition of cell division by tissue structure; however, the underlining molecular circuitry for this regulation remains unclear. Recently, the Yap transcriptional co-activator has emerged as a key growth promoter that mediates contact growth arrest and limits organ size. Thus, we aimed to uncover upstream signals that connect tissue organization to Yap regulation in the inhibition of cervical cancer. Two events that disrupt tissue structure were examined including the loss of the tumor suppressor LKB1 and the expression of the viral oncogene HPV16-E6. We identified that Yap mediates cell growth regulation downstream of both LKB1 and E6. Restoration of LKB1 expression in HeLa cervical cancer cells, which lack this tumor suppressor, or shRNA knockdown of LKB1 in NTERT immortalized normal human dermal keratinocytes, demonstrated that LKB1 promotes Yap phosphorylation, nuclear exclusion, and proteasomal degradation. The ability of phosphorylation-defective Yap mutants to rescue LKB1 phenotypes, such as reduced cell proliferation and cell size, suggest that Yap inhibition contributes to LKB1 tumor suppressor function(s). Interestingly, LKB1’s suppression of Yap activity required neither the canonical Yap kinases, Lats1/2, nor metabolic downstream targets of LKB1, AMPK and mTORC1. Instead, the scaffolding protein NF2 was required for LKB1 to induce a specific actin cytoskeleton structure that associates with Yap suppression. Meanwhile, HPV16-E6 promoted Yap activation in all stages of keratinocyte differentiation. E6 activated the Rap1 small GTPase, which in turn promoted Yap activity. Since Rap1 does not mediate differentiation inhibition caused by E6, E6 may play a role in promoting cell growth through Rap1-Yap activation rather than preventing growth arrest through the disruption of differentiation. Altogether, the LKB1-NF2-Yap and E6-Rap1-Yap pathways represent two examples of a novel phenomenon, whereby the structure of a cell directly influences its gene expression and proliferation.